364 related articles for article (PubMed ID: 18200028)
1. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA
Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T
Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
[TBL] [Abstract][Full Text] [Related]
5. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
[TBL] [Abstract][Full Text] [Related]
6. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
[TBL] [Abstract][Full Text] [Related]
7. Estrogen modulates bone marrow-derived DCs in SLE murine model-(NZB x NZW) F1 female mice.
Jiang B; Sun L; Hao S; Li X; Xu Y; Hou Y
Immunol Invest; 2008; 37(3):227-43. PubMed ID: 18389442
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
10. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
[TBL] [Abstract][Full Text] [Related]
11. Genetic studies on the skin lupus band test in New Zealand mice.
Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T
Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
Hayashi T; Hasegawa K; Sasaki Y; Mori T; Adachi C; Maeda K
Nephrol Dial Transplant; 2007 Nov; 22(11):3131-8. PubMed ID: 17670770
[TBL] [Abstract][Full Text] [Related]
13. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
Dong L; Ito S; Ishii KJ; Klinman DM
Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
[TBL] [Abstract][Full Text] [Related]
14. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
[TBL] [Abstract][Full Text] [Related]
16. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
18. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
[TBL] [Abstract][Full Text] [Related]
20. Resistance to tolerance induction is not prerequisite to development of murine SLE.
Izui S; Masuda K
J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
